Medicine and Dentistry
Intensive Care Unit
100%
Intensive Care
89%
Cardiology
73%
COVID-19
62%
Hospital Mortality
57%
Coronary Artery Bypass Graft
51%
Coronary Artery Disease
47%
Artificial Respiration
45%
Cardiogenic Shock
41%
Heart Muscle Revascularization
41%
Clinician
40%
Noninvasive Ventilation
39%
Coronary Artery Bypass Graft Surgery
39%
Heart Surgery
39%
Assisted Ventilation
38%
Acute Respiratory Distress Syndrome
36%
Shock (Circulatory)
36%
Acute Decompensated Heart Failure
35%
Coronary Artery Recanalization
35%
Heart Failure
33%
Odds Ratio
31%
Prevalence
31%
Heart Muscle Injury
31%
Cardiovascular System
31%
Cardiovascular Disease
31%
Percutaneous Coronary Intervention
30%
Respiratory Failure
26%
Critical Illness
24%
Human Immunodeficiency Virus
23%
Echocardiography
23%
Cohort Analysis
19%
Clinical Trial
18%
Cardiac Troponin
17%
Troponin I
17%
Point-of-Care Ultrasound
17%
Antiplatelet
17%
Transesophageal Echocardiography
17%
Isotopes of Calcium
17%
Acute Coronary Syndrome
16%
Logistic Regression Analysis
16%
Myocardial Infarction
15%
Revascularization
15%
Diastolic Dysfunction
15%
Pulmonary Hypertension
15%
Assisted Circulation
15%
Cohort Effect
13%
Hemodynamic
13%
Human Subject
13%
Artery Compliance
12%
Disease
12%
Keyphrases
Cardiac Intensive Care Unit
56%
Acute Respiratory Distress Syndrome
54%
Coronary Artery Bypass Grafting
52%
COVID-19
46%
Myocardial Injury
45%
Cardiac Surgery
42%
Coronary Revascularization
36%
Critical Care Cardiology
35%
In-hospital Mortality
30%
Noninvasive Ventilation
28%
Respiratory Support
28%
Clinical Practice Guidelines
28%
Trial Network
27%
Acute Heart Failure
26%
Joint Committees
26%
Coronary Artery Bypass Graft Surgery
26%
Shock
23%
Cardiovascular Disease
21%
Maryland
21%
Retrospective Cohort Study
19%
Respiratory Failure
19%
Invasive Mechanical Ventilation
18%
Clinical Trials
18%
Critical Illness
18%
COVID-19 Patients
17%
ST-elevation Myocardial Infarction (STEMI)
17%
High-sensitivity Cardiac Troponin
17%
Hospitalized Patients
17%
HIV Patients
17%
Heart Team
17%
Transesophageal Echocardiography
17%
Dual Antiplatelet Therapy
17%
Troponin
16%
Confidence Interval
16%
Percutaneous Coronary Intervention
16%
Coronary Artery Disease
16%
Myocardial Infarction
15%
High-sensitivity Troponin I
15%
Odds Ratio
13%
Acute Coronary Syndrome
13%
Cardiogenic Shock
13%
Heart Failure Patients
12%
C-reactive Protein
12%
Systemic Inflammation
12%
Inflammation
11%
Clinical Outcomes
11%
Patients with COVID-19
11%
Cardiac Patients
11%
Epidemiology
11%
Risk Prediction
11%
